395 related articles for article (PubMed ID: 9278317)
21. Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses.
Gramaglia I; Weinberg AD; Lemon M; Croft M
J Immunol; 1998 Dec; 161(12):6510-7. PubMed ID: 9862675
[TBL] [Abstract][Full Text] [Related]
22. Induction of germinal center B cell markers in vitro by activated CD4+ T lymphocytes: the role of CD40 ligand, soluble factors, and B cell antigen receptor cross-linking.
Lahvis GP; Cerny J
J Immunol; 1997 Aug; 159(4):1783-93. PubMed ID: 9257841
[TBL] [Abstract][Full Text] [Related]
23. CD40 is necessary for activation of naïve T cells by a dendritic cell line in vivo but not in vitro.
Haase C; Michelsen BK; Jørgensen TN
Scand J Immunol; 2004 Mar; 59(3):237-45. PubMed ID: 15030573
[TBL] [Abstract][Full Text] [Related]
24. A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory.
Bourgeois C; Rocha B; Tanchot C
Science; 2002 Sep; 297(5589):2060-3. PubMed ID: 12242444
[TBL] [Abstract][Full Text] [Related]
25. Regulation of CD40 ligand expression on naive CD4 T cells: a role for TCR but not co-stimulatory signals.
Jaiswal AI; Dubey C; Swain SL; Croft M
Int Immunol; 1996 Feb; 8(2):275-85. PubMed ID: 8671613
[TBL] [Abstract][Full Text] [Related]
26. Differential effects of CD28 engagement and IL-12 on T cell activation by altered peptide ligands.
Ding L; Shevach EM
J Immunol; 1998 Dec; 161(12):6614-21. PubMed ID: 9862689
[TBL] [Abstract][Full Text] [Related]
27. Role and expression of CD40 on human retinal pigment epithelial cells.
Willermain F; Caspers-Velu L; Baudson N; Dubois C; Hamdane M; Willems F; Velu T; Bruyns C
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3485-91. PubMed ID: 11006243
[TBL] [Abstract][Full Text] [Related]
28. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.
Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H
J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104
[TBL] [Abstract][Full Text] [Related]
29. B lymphocytes as antigen-presenting cells for CD4+ T cell priming in vivo.
Constant SL
J Immunol; 1999 May; 162(10):5695-703. PubMed ID: 10229801
[TBL] [Abstract][Full Text] [Related]
30. Selective antigen presenting activity of cortical thymic epithelial cells against CD4+ T cells associated with both lack of costimulatory molecules and inefficient presentation of MHC-peptide ligands.
Kaneda R; Iwabuchi K; Kasai M; Murakami M; Uede T; Onoé K
Cell Immunol; 1997 Nov; 181(2):163-71. PubMed ID: 9398403
[TBL] [Abstract][Full Text] [Related]
31. Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo.
Kleindienst P; Brocker T
Immunology; 2005 Aug; 115(4):556-64. PubMed ID: 16011524
[TBL] [Abstract][Full Text] [Related]
32. IL-4-producing CD8+ T cell clones can provide B cell help.
Cronin DC; Stack R; Fitch FW
J Immunol; 1995 Apr; 154(7):3118-27. PubMed ID: 7897202
[TBL] [Abstract][Full Text] [Related]
33. CD40 and its ligand in the regulation of humoral immunity.
Klaus SJ; Berberich I; Shu G; Clark EA
Semin Immunol; 1994 Oct; 6(5):279-86. PubMed ID: 7532458
[TBL] [Abstract][Full Text] [Related]
34. Normal B cells fail to secrete interleukin-12.
Guéry JC; Ria F; Galbiati F; Adorini L
Eur J Immunol; 1997 Jul; 27(7):1632-9. PubMed ID: 9247571
[TBL] [Abstract][Full Text] [Related]
35. Human rheumatoid factor production is dependent on CD40 signaling and autoantigen.
Kyburz D; Corr M; Brinson DC; Von Damm A; Tighe H; Carson DA
J Immunol; 1999 Sep; 163(6):3116-22. PubMed ID: 10477577
[TBL] [Abstract][Full Text] [Related]
36. B-cell expansion in the presence of the novel 293-CD40L-sCD40L cell line allows the generation of large numbers of efficient xenoantigen-free APC.
Ivanov R; Aarts T; Hagenbeek A; Hol S; Ebeling S
Cytotherapy; 2005; 7(1):62-73. PubMed ID: 16040385
[TBL] [Abstract][Full Text] [Related]
37. Cytotoxicity and weak CD40 ligand expression of CD8+ type 2 cytotoxic T cells restricts their potential B cell helper activity.
Sad S; Krishnan L; Bleackley RC; Kägi D; Hengartner H; Mosmann TR
Eur J Immunol; 1997 Apr; 27(4):914-22. PubMed ID: 9130644
[TBL] [Abstract][Full Text] [Related]
38. Induction and inhibition of CD40-CD40 ligand interactions: a new strategy underlying host-virus relationships.
Sharma MD; Leite de Moraes M; Zavala F; Pontoux C; Papiernik M
J Immunol; 1998 Nov; 161(10):5357-65. PubMed ID: 9820509
[TBL] [Abstract][Full Text] [Related]
39. CD4+ T cell responses to CD40-deficient APCs: defects in proliferation and negative selection apply only with B cells as APCs.
Ozaki ME; Coren BA; Huynh TN; Redondo DJ; Kikutani H; Webb SR
J Immunol; 1999 Nov; 163(10):5250-6. PubMed ID: 10553046
[TBL] [Abstract][Full Text] [Related]
40. Endothelial cells augment the expression of CD40 ligand on newly activated human CD4+ T cells through a CD2/LFA-3 signaling pathway.
Karmann K; Hughes CC; Fanslow WC; Pober JS
Eur J Immunol; 1996 Mar; 26(3):610-7. PubMed ID: 8605928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
